Indication
Non-Keratinizing Nasopharyngeal Carcinoma
Non-keratinizing nasopharyngeal carcinoma is an epithelial malignancy arising from the mucosal lining of the nasopharynx, predominantly originating in the pharyngeal recess (fossa of Rosenmüller). Read more about Non-Keratinizing Nasopharyngeal Carcinoma
0 drugs 0 manufacturers
Drugs that treat it
Common Non-Keratinizing Nasopharyngeal Carcinoma therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNon-keratinizing nasopharyngeal carcinoma is an epithelial malignancy arising from the mucosal lining of the nasopharynx, predominantly originating in the pharyngeal recess (fossa of Rosenmüller).
It represents the vast majority of nasopharyngeal carcinoma cases globally and is strongly endemic to East and Southeast Asia as well as parts of North Africa.
Pathophysiologically, it is nearly universally driven by latent Epstein-Barr virus infection and is histologically subclassified into differentiated and undifferentiated variants, the latter historically termed lymphoepithelioma.
Defining clinical features include a high propensity for early regional cervical lymphadenopathy and distant metastasis, paired with pronounced sensitivity to platinum-based chemotherapy and radiation.
- nih.gov
Non-keratinizing nasopharyngeal carcinoma is an epithelial malignancy arising from the mucosal lining of the nasopharynx, predominantly originating in the pharyngeal recess (fossa of Rosenmüller) It represents the vast majority of nasopharyngeal carcinoma cases globally and is strongly endemic to East and Southeast Asia as well as parts of North Africa Defining clinical features include a high propensity for early regional cervical lymphadenopathy and distant metastasis, paired with pronounced s...
- nih.gov
Non-keratinizing nasopharyngeal carcinoma is an epithelial malignancy arising from the mucosal lining of the nasopharynx, predominantly originating in the pharyngeal recess (fossa of Rosenmüller)
- nih.gov
Non-keratinizing nasopharyngeal carcinoma is an epithelial malignancy arising from the mucosal lining of the nasopharynx, predominantly originating in the pharyngeal recess (fossa of Rosenmüller)
- nih.gov
It represents the vast majority of nasopharyngeal carcinoma cases globally and is strongly endemic to East and Southeast Asia as well as parts of North Africa
- mypathologyreport.ca
It represents the vast majority of nasopharyngeal carcinoma cases globally and is strongly endemic to East and Southeast Asia as well as parts of North Africa Pathophysiologically, it is nearly universally driven by latent Epstein-Barr virus infection and is histologically subclassified into differentiated and undifferentiated variants, the latter historically termed lymphoepithelioma Defining clinical features include a high propensity for early regional cervical lymphadenopathy and distant met...
- cancer.gov
Pathophysiologically, it is nearly universally driven by latent Epstein-Barr virus infection and is histologically subclassified into differentiated and undifferentiated variants, the latter historically termed lymphoepithelioma
- nih.gov
Pathophysiologically, it is nearly universally driven by latent Epstein-Barr virus infection and is histologically subclassified into differentiated and undifferentiated variants, the latter historically termed lymphoepithelioma
- nih.gov
Pathophysiologically, it is nearly universally driven by latent Epstein-Barr virus infection and is histologically subclassified into differentiated and undifferentiated variants, the latter historically termed lymphoepithelioma
- nih.gov
Defining clinical features include a high propensity for early regional cervical lymphadenopathy and distant metastasis, paired with pronounced sensitivity to platinum-based chemotherapy and radiation
- nih.gov
Defining clinical features include a high propensity for early regional cervical lymphadenopathy and distant metastasis, paired with pronounced sensitivity to platinum-based chemotherapy and radiation
Personalize your experience
Follow Non-Keratinizing Nasopharyngeal Carcinoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.